Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | Graceful Self-promotion: Empower Yourself as a Leader in Neurology (and Kick the Imposter Syndrome)

Wednesday 04/06/22
12:00 PM - 01:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Learner Engagement Center (Leadership University)
Susanne Muehlschlegel, MD, MPH, FAAN
Leadership
Graceful self-promotion is a way of speaking diplomatically and strategically about yourself and your accomplishments. This workshop will provide background knowledge and equip the learner with important tools for graceful self-promotion and overcoming the Imposter Syndrome. Topics include graceful self-promotion, a confident introduction, PAR statements, the elevator speech, and using Twitter (or other social media) and promoting others to empower oneself as a leader. Limited spots are available in this workshop.
1.50 CME credits
Interpersonal and Communication Skills, Professionalism
Introductory
Diversity, Equity, and Inclusion
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Neurohospitalist, Medical Student
Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
12:00 PM - 01:30 PM PDT Speaker Graceful Self-Promotion: Empower Yourself as a Leader in Neurology (and Kick the Imposter Syndrome)
Susanne Muehlschlegel, MD, MPH, FAAN
Faculty Disclosures
Susanne Muehlschlegel, MD, MPH, FAAN Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma Inc.. Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.